May 10, 2018 / 12:12 PM / 6 months ago

BRIEF-Catabasis Pharmaceuticals Reports Q1 Loss Per Share $0.29

May 10 (Reuters) - Catabasis Pharmaceuticals Inc:

* CATABASIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS

* Q1 LOSS PER SHARE $0.29

* Q1 EARNINGS PER SHARE VIEW $-0.20 -- THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, 2018, CATABASIS HAD CASH AND CASH EQUIVALENTS OF $17.0 MILLION

* BELIEVES THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS THROUGH DECEMBER 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below